Skip to main content
Equibles

SGIOF · Shionogi & Co Ltd · Metrics

Track SGIOF — free

Use SGIOF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SGIOF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$19.39 -1.46 (-7.00%) At close · Nov 9
Rebalance outlook locked
Market Cap
$16.50B
Shares
851.17M
Volume · Nov 9 2825 Avg daily vol (12 sessions) 419

SGIOF metrics

42 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$19.39
Market cap
$16.50B

Price action

23 metrics
Price change (1W)
-7.0%
Price change (30D)
+7.7%
Price change (3M)
+8.3%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
+7.1%
Trailing year
Price change (5Y)
—
52-week high
$26.00
52-week low
$15.21
Change from 52-week high
-25.4%
Change from 52-week low
+27.5%
Annualized volatility
—
Annualized volatility (3M)
—
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
—
RSI (14D)
53.5
Price vs SMA 50
+3.0%
Price vs SMA 200
—
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
851.17M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
2.3%
Trailing 12 months
Payout ratio
25.1%
Shareholder yield
—
Dividend / share (TTM)
$0.45
Dividend growth YoY
+1.6%
Dividend growth streak
3
Last ex-dividend
2026-09-29

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
81.6%
Operating margin
32.5%
Trailing 12 months
Net margin
37.9%
Gross profit (TTM)
$520.10B
Operating profit (TTM)
$207.20B
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
38.7%
Effective tax rate
2.3%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+14.0%
Year over year
Net income growth YoY
+20.4%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
—
Year over year · more shares
Revenue CAGR (3Y)
+5.4%
Revenue CAGR (5Y)
+11.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+6.2%
FCF CAGR (5Y)
+19.7%

Quality

14 metrics
Return on equity
13.8%
Return on assets
9.1%
Debt / equity
—
Current ratio
1.2
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
—
Total assets
—
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.5%
Latest settlement · 999+ days to cover
Days to cover
999+
Short-squeeze score
47 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1281721 Visit website Investor relations